List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 67 studies with search of: Ribavirina OR Copegus, Rebetol, Virazole[TREATMENT] AND HIV [CONDITION]
Hide studies that are not seeking new volunteers.
Hide studies with unknown recruitment status.
  Display Options
Rank Status Study
1 Active, not recruiting Telaprevir In HIV-HCV Coinfected Patients Who Had Previously Failed A Peginterferon-Ribavirin Regimen
Conditions: Hepatitis C, Chronic;   HIV Infection
Interventions: Drug: Telaprevir;   Biological: peginterferon alfa-2a;   Drug: Ribavirin
2 Completed Viral Kinetics of Treatment With Peginterferon Alpha-2a, Ribavirin and Epoetin β in Patients Coinfected HCV/HIV
Condition: HIV Infections
Interventions: Drug: Peginterferon alfa-2a, Ribavirin, epoetin-β;   Drug: Peginterferon alfa-2a + Ribavirin for 12 weeks
3 Completed
Has Results 		Peginterferon Alpha-2a and Ribavirin to Treat Hepatitis C in HIV-infected Patients
Conditions: Hepatitis C;   HIV Infections
Interventions: Drug: Double dose pegylated interferon with weight based Ribavirin;   Drug: standard dose pegylated interferon alfa -2a and ribavirin
4 Completed Retreatment With High Doses of pegIFN Alfa-2a and Ribavirin of Previous Nonresponders HIV-coinfected Patients With Cirrhosis Due to HCV 1-4
Conditions: Liver Cirrhosis;   Hepatitis C Virus;   HIV Infection
Intervention: Drug: Pegylated interferon alfa-2a and Ribavirin
5 Completed Low Dose Peginterferon-α 2a for Chronic Hepatitis C, Genotypes 2 or 3, in HIV-coinfected Patients
Conditions: Hepatitis C, Chronic;   HIV Infections
Interventions: Drug: Pegylated interferon alfa-2a and Ribavirin;   Drug: Pegylated interferon alfa 2a and Ribavirin
6 Active, not recruiting Boceprevir in HIV-HCV Coinfected Patients Who Have Failed to a Previous Therapy With Peg-Interferon/Ribavirin
Conditions: HCV Coinfection;   HIV-1 Infection
Intervention: Drug: Boceprevir, Peg-interferon alfa 2b and Ribavirin
7 Completed Zidovudine Levels in HIV Infected Patients Being Treated for HCV
Conditions: HIV Infections;   Hepatitis C
Interventions: Drug: Ribavirin plus interferon alfa-2b;   Drug: Ribavirin;   Drug: Peginterferon alfa-2b
8 Completed
Has Results 		Nitazoxanide Plus Ribavirin and Peginterferon for Therapy of Treatment Naive HCV Genotype 1 and HIV Coinfected Subjects
Conditions: HIV Infection;   Hepatitis C Infection
Interventions: Drug: Nitazoxanide (NTZ);   Drug: Pegylated interferon alfa-2a (PEG);   Drug: Ribavirin (RBV)
9 Completed Peginterferon Alfa-2a, Ribavirin and Epoetin β in Coinfected Patients HCV/HIV Not Responding to Previous Treatment Regimens
Conditions: Hepatitis C;   HIV Infections
Interventions: Drug: Peginterferón alfa-2a (40 KD) (Pegasys®) 180 ug/week;   Drug: Ribavirin (Copegus®) 1600 mg/day;   Drug: Epoetin β (450 UI/kg/week)
10 Completed Post-marketing Surveillance of HIV-infected Patients With Chronic Hepatitis C Treated With PegIntron Pen and Rebetol (Study P04584)
Conditions: Chronic Hepatitis C;   Hepatitis C;   HIV Infections
Interventions: Biological: PegIntron (peginterferon alfa-2b; SCH 54031) pen;   Drug: Rebetol (ribavirin; SCH 18908)
11 Completed Efficacy and Safety of Addition of IL-2 to Pegylated Interferon Alpha 2a and Ribavirin in HIV/HCV Coinfected Patients
Conditions: HIV Infections;   Chronic Hepatitis C
Interventions: Drug: Interleukin 2;   Drug: pegylated interferon alpha 2a;   Drug: ribavirin
12 Completed
Has Results 		The Raltegravir and Ribavirin Pharmacokinetics (PK) Study
Condition: HIV Infections
Interventions: Drug: Ribavirin;   Drug: Raltegravir
13 Terminated
Has Results 		Efficacy and Safety of PegIntron Plus Ribavirin for Treatment of Chronic Hepatitis C in HIV-Infected Subjects (Study P04469)(TERMINATED)
Conditions: Hepatitis C, Chronic;   Hepacivirus;   HIV Infections
Interventions: Biological: Peginterferon alfa-2b (SCH 054031);   Drug: Ribavirin (SCH 018908)
14 Completed Safety and Efficacy of Telaprevir in Combination With Peginterferon Alfa-2a and Ribavirin in Subjects Co-Infected With Hepatitis C Virus (HCV) and HIV
Conditions: Hepatitis C;   HIV Infections
Interventions: Drug: telaprevir or matching placebo;   Biological: peginterferon alfa-2a;   Drug: ribavirin (fixed dose);   Drug: ribavirin (weight-based dose)
15 Completed Treatment of Chronic Hepatitis C With PEG Interferon alfa2a and Ribavirin in HIV-Infected Patients
Conditions: HIV Infections;   Hepatitis C, Chronic;   Treatment Failure
Interventions: Drug: Peginterferon alfa2a;   Drug: Ribavirin
16 Completed Interactions of Hepatitis C Viral (HCV) Dynamics and Immune Activation in HIV Coinfected Patients During HCV Treatment
Conditions: Human Immunodeficiency Virus;   Chronic Hepatitis C
Interventions: Drug: pegylated interferon-alpha (Pegasys);   Drug: ribavirin (COPEGUS)
17 Terminated Tolerability of Peginterferon Plus Ribavirin for Chronic Hepatitis C and HIV for Patients Receiving Antiretroviral Medication vs Not Receiving Antiretroviral Medication
Conditions: Chronic Hepatitis C;   HIV Infections
Intervention: Drug: peg interferon plus ribavirin
18 Completed A Phase I Open-Label Study of the Safety, Tolerance, and Pharmacokinetic Interactions of Combination Didanosine and Ribavirin in HIV-Positive Individuals
Condition: HIV Infections
Interventions: Drug: Ribavirin;   Drug: Didanosine
19 Completed Phase I Pharmacokinetic and Tolerance Study of Ribavirin in Human Immunodeficiency Virus (HIV) - Infected Patients
Condition: HIV Infections
Intervention: Drug: Ribavirin
20 Completed A Phase I Study of Combination Therapy With Didanosine (ddI) and Ribavirin in HIV-Infected Children.
Condition: HIV Infections
Interventions: Drug: Ribavirin;   Drug: Didanosine

Previous Page Studies Shown (1-20) Next Page (21-40)
† Indicates status has not been verified in more than two years
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services